May 23, 2012

All men know: It’s not the fall that kills you; it’s that sudden stop at the end. Men smoke more, drink more and eat more. Men die sooner and are less likely to seek health care on their own. Men are full-throttle all-systems-go, until one day they’re not. Because it’s that sudden run-in with a heart attack or stroke, that sudden diagnosis of prostate or colon cancers, that slows them down.

May 15, 2012

A former football coach is joining an effort to educate men about the risks of a deadly form of skin cancer.

May 9, 2012

The Skin Cancer Foundation's Road to Healthy Skin Tour, presented by Aveeno and Rite Aid, once again is touring the country to raise skin cancer awareness.

May 9, 2012

Seattle Genetics and Takeda's cancer drug subsidiary have started a late-stage clinical trial for a lymphoma drug, the companies said Wednesday.

May 3, 2012

Walgreens Specialty Pharmacy on Thursday added six medications to its oral oncology cycle management program, in a significant expansion of the comprehensive treatment and support program it provides to benefit patients, physicians and payers, the company announced.

May 2, 2012

Beauty company Coty and DKMS, the world's largest bone marrow donor center, jointly raised $3.2 million to support the fight against blood cancer during the recently held DKMS 6th Annual Gala: Linked Against Blood Cancer.

April 30, 2012

An online plea for help from a mother dying of breast cancer prompted the manufacturer of an experimental drug to release it early, according to published reports.

April 27, 2012

The Food and Drug Administration has approved a drug made by GlaxoSmithKline for certain cancer patients.

April 2, 2012

A medication commonly prescribed for patients with Type 2 diabetes also may play a critical role in patients at risk of developing certain cancers.

March 30, 2012

Breast cancer patients taking an experimental drug made by Roche subsidiary Genentech lived significantly longer than those taking another drug made by GlaxoSmithKline, according to results of a late-stage clinical trial.

March 30, 2012

Mortality rates from all cancers combined continued to drop between 2004 and 2008 among men, women and children, according to the annual "Report to the Nation on the Status of Cancer, 1975-2008."

March 23, 2012

Evidence supporting the daily use of aspirin to help prevent and possibly treat cancer was published Tuesday in a collection of three papers — two in The Lancet and one in Lancet Oncology.

March 21, 2012

A Food and Drug Administration expert panel delivered a favorable vote on a cancer drug made by GlaxoSmithKline.

March 16, 2012

Pills for treating cancer have created numerous alternatives to spending hours in a clinic or at home receiving chemotherapy infusions, but risks of drug interactions remain, according to a new survey by the research arm of pharmacy benefit manager Medco Health Solutions.

March 15, 2012

In line with National Colorectal Cancer Awareness Month, Winn-Dixie is offering customers the chance to pick up a free test at its pharmacies.

February 17, 2012

A specialty pharmacy provider has begun selling a drug made by Pfizer for treating kidney cancer.

February 8, 2012

Specialty pharmacy provider The Apothecary Shops has inked a deal with Pfizer to distribute a new drug for treating kidney cancer.

January 30, 2012

The FDA announced the approval of Genentech's Erivedge (vismodegib) for adults with basal cell carcinoma who are not surgery or radiation therapy candidates and whose disease is locally advanced or has spread to other parts of the body.

December 21, 2011

Skin care brand La Roche-Posay is partnering with Mollie's Fund, the Mollie Biggane Melanoma Foundation, in its mission to increase awareness for melanoma prevention.

December 9, 2011

Diplomat Specialty Pharmacy has signed an agreement with a provider of acquisition and management services for oral cancer drugs that the companies said would allow for better access to the drugs and related programs.

December 1, 2011

A new study conducted by researchers at Yeshiva University's Albert Einstein College of Medicine found that high blood-sugar levels may be associated with an increased risk of colorectal cancer.

November 28, 2011

A drug commonly used to treat Type 2 diabetes may reduce the risk of diabetes-associated cancers, including breast cancer, according to a new study.

November 21, 2011

A drug made by Amgen delayed the spread of prostate cancer to the bones in men with the disease and prolonged the survival of men with the condition, according to results of a late-stage clinical trial.

November 18, 2011

A drug widely used to treat breast cancer is not safe or effective, the Food and Drug Administration said Friday.